FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices – Includes Caremark, Express Scripts, ...
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
The vice president has campaigned on holding big business accountable but has privately sought advice from CEOs and investors ...
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of ...
She advised the government to eliminate middlemen in the sale of cancer drugs ... “When you get a drug and find out it’s not working, a higher one is recommended and you spend more than ...
One complicating factor is manufacturer rebates, which are discounts on prescription list prices provided by drug manufacturers to pharmacy benefit managers, which in turn may share some or all of ...
essentially middlemen in the supply chain, are manipulating the drug pricing process for their own profit. The six largest PBMs control 95% of the prescription drug marketplace and they are ...
In July, the U.S. Federal Trade Commission published a report that alleged how prescription drug middlemen profit at patients’ expense by inflating drug costs and negatively affecting accessibility ...
The Dean of the Faculty of Renewable Natural Resources, University of Ibadan, Professor Adejoke Akinyele, has called on the federal government to eliminate the activities of middlemen in the food ...
It’s no secret that prescription drugs are unaffordable for many Californians. In just five years, spending on prescription drugs ballooned from $8.7 billion to $12.1 billion, an increase of 39% ...
the drug companies claim that they ultimately have to raise list prices in order to pay the middlemen.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback